Federal Research Institute of Pediatric Hematology, Oncology and Immunology

🇷🇺Russia
Ownership
Private
Employees
-
Market Cap
-
Website

Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy

Not Applicable
Recruiting
Conditions
First Posted Date
2021-02-21
Last Posted Date
2023-03-08
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
150
Registration Number
NCT04761965
Locations
🇷🇺

Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Samory-Mashela,1, Russian Federation

Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2021-01-25
Last Posted Date
2021-01-25
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
180
Registration Number
NCT04723342
Locations
🇷🇺

Almazov National Medical Research Centre, Saint Petersburg, Russian Federation

🇷🇺

Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

🇷🇺

National Medical Research Center of Oncology named after N.N. Blokhin, Moscow, Russian Federation

and more 1 locations

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)

Phase 2
Conditions
Interventions
First Posted Date
2020-10-20
Last Posted Date
2020-12-01
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
15
Registration Number
NCT04593368
Locations
🇷🇺

Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russian Federation

🇷🇺

Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

🇷🇺

RM Gorbacheva Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov University, Saint Petersburg, Russian Federation

Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.

First Posted Date
2020-10-01
Last Posted Date
2020-10-01
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
30
Registration Number
NCT04572620
Locations
🇷🇺

Dmitry Rogachev National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2020-08-05
Last Posted Date
2023-02-22
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
50
Registration Number
NCT04499573
Locations
🇷🇺

Federal Research Institute of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome

Phase 2
Conditions
Interventions
First Posted Date
2020-05-22
Last Posted Date
2020-06-25
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
10
Registration Number
NCT04400045
Locations
🇷🇺

HSCT department, Moscow, Russian Federation

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

First Posted Date
2020-05-01
Last Posted Date
2020-05-06
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
30
Registration Number
NCT04371939
Locations
🇷🇺

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

Completed
Conditions
Interventions
First Posted Date
2020-04-16
Last Posted Date
2020-12-28
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
67
Registration Number
NCT04350164
Locations
🇷🇺

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2019-10-23
Last Posted Date
2020-04-07
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
13
Registration Number
NCT04136028
Locations
🇷🇺

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias

First Posted Date
2019-06-27
Last Posted Date
2020-11-20
Lead Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Target Recruit Count
25
Registration Number
NCT04000698
Locations
🇷🇺

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

© Copyright 2024. All Rights Reserved by MedPath